Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$95.25
-0.2%
$88.95
$81.97
$137.49
$165.91B0.6113.09 million shs10.63 million shs
Aphria Inc. stock logo
APHA
Aphria
C$0.00
C$3.93
C$40.93
C$5.24BN/A6.16 million shs9.61 million shs
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$4.93
+0.5%
$5.24
$4.57
$8.69
$1.84B0.422.80 million shs3.27 million shs
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
$49.38
-0.1%
$49.36
$42.62
$80.69
$2.34B0.35704,869 shs561,926 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+1.31%+4.44%-6.89%-28.75%
Aphria Inc. stock logo
APHA
Aphria
0.00%0.00%0.00%0.00%0.00%
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
0.00%+2.93%-8.37%-8.54%-29.13%
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
0.00%+0.01%+4.75%-10.46%-38.26%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$95.25
-0.2%
$88.95
$81.97
$137.49
$165.91B0.6113.09 million shs10.63 million shs
Aphria Inc. stock logo
APHA
Aphria
C$0.00
C$3.93
C$40.93
C$5.24BN/A6.16 million shs9.61 million shs
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$4.93
+0.5%
$5.24
$4.57
$8.69
$1.84B0.422.80 million shs3.27 million shs
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
$49.38
-0.1%
$49.36
$42.62
$80.69
$2.34B0.35704,869 shs561,926 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+1.31%+4.44%-6.89%-28.75%
Aphria Inc. stock logo
APHA
Aphria
0.00%0.00%0.00%0.00%0.00%
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
0.00%+2.93%-8.37%-8.54%-29.13%
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
0.00%+0.01%+4.75%-10.46%-38.26%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.89
Moderate Buy$118.4224.32% Upside
Aphria Inc. stock logo
APHA
Aphria
0.00
N/AN/AN/A
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
1.80
Reduce$8.0062.44% Upside
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
2.00
Hold$70.7543.27% Upside

Current Analyst Ratings Breakdown

Latest ABT, APHA, PBH, and BHC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/1/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Initiated CoverageOutperform$121.00
6/30/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
UpgradeStrong-Buy
6/25/2026
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
DowngradeHold (C-)Sell (D+)
6/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Reiterated RatingOverweight$115.00
6/16/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeHold (C-)Sell (D+)
6/12/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price Target$120.00 ➝ $102.00
5/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$121.00 ➝ $113.00
5/18/2026
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
DowngradeHoldStrong Sell
5/15/2026
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
Lower Price TargetBuy$86.00 ➝ $72.00
5/14/2026
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
DowngradeHold (C)Hold (C-)
5/14/2026
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
DowngradeOutperformMarket Perform
(Data available from 7/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B3.74$6.98 per share13.65$30.35 per share3.14
Aphria Inc. stock logo
APHA
Aphria
C$611.06M0.00N/A22.40C$4.76 per share0.00
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$10.27B0.18$7.35 per share0.67$1.02 per share4.83
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
$1.09B2.15$5.20 per share9.49$39.89 per share1.24
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.5726.6815.741.6413.90%17.62%10.01%7/16/2026 (Estimated)
Aphria Inc. stock logo
APHA
Aphria
N/A-C$2.01N/AN/AN/AN/AN/AN/AN/A
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$157M-$3.24N/A1.35N/A-11.47%-2,922.77%5.63%7/29/2026 (Estimated)
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
$190.30M$3.9112.6310.461.5917.48%11.54%6.16%8/6/2026 (Estimated)

Latest ABT, APHA, PBH, and BHC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2026Q2 2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$0.96N/AN/AN/A$2.56 billionN/A
7/16/2026Q2 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.28N/AN/AN/A$12.52 billionN/A
5/13/2026Q4 2026
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
$1.39$1.23-$0.16$1.13$293.64 million$281.62 million
4/29/2026Q1 2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$0.81$0.78-$0.03-$3.76$2.37 billion$2.46 billion
4/16/2026Q1 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.14$1.15+$0.01$0.61$10.99 billion$11.16 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.65%+10.39%70.59%54 Years
Aphria Inc. stock logo
APHA
Aphria
N/AN/AN/AN/AN/A
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
N/AN/AN/AN/AN/A
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
N/AN/AN/AN/AN/A

Latest ABT, APHA, PBH, and BHC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/12/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.87%7/15/20267/15/20268/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.56
1.39
1.01
Aphria Inc. stock logo
APHA
Aphria
59.29
3.37
1.63
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
54.68
1.32
0.97
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
0.54
3.57
2.25

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Aphria Inc. stock logo
APHA
Aphria
N/A
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
78.65%
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
99.95%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Aphria Inc. stock logo
APHA
Aphria
N/A
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
20.67%
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
1.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
Aphria Inc. stock logo
APHA
Aphria
1,200316.80 millionN/ANot Optionable
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
20,300374.02 million296.71 millionOptionable
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
54047.37 million46.66 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$95.25 -0.15 (-0.16%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$95.45 +0.20 (+0.21%)
As of 06:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Aphria stock logo

Aphria TSE:APHA

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Bausch Health Cos stock logo

Bausch Health Cos NYSE:BHC

$4.92 +0.03 (+0.51%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$4.95 +0.03 (+0.51%)
As of 05:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Prestige Consumer Healthcare stock logo

Prestige Consumer Healthcare NYSE:PBH

$49.38 -0.04 (-0.07%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$49.42 +0.04 (+0.08%)
As of 07/2/2026 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.